0001486988-11-000003.txt : 20110510 0001486988-11-000003.hdr.sgml : 20110510 20110509195413 ACCESSION NUMBER: 0001486988-11-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20110510 DATE AS OF CHANGE: 20110509 EFFECTIVENESS DATE: 20110510 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Elcelyx Therapeutics, Inc. CENTRAL INDEX KEY: 0001486988 IRS NUMBER: 264373248 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-154368 FILM NUMBER: 11825379 BUSINESS ADDRESS: STREET 1: 11995 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 876-1814 MAIL ADDRESS: STREET 1: 11995 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 D/A 1 primary_doc.xml X0704 D/A LIVE 0001486988 Elcelyx Therapeutics, Inc. 11995 EL CAMINO REAL SUITE 305 SAN DIEGO CA CALIFORNIA 92130 (858) 876-1814 DELAWARE None None Corporation true 2009 Alain D. Baron c/o Elcelyx Therapeutics, Inc. 11995 El Camino Real, Suite 305 San Diego CA CALIFORNIA 92130 Executive Officer Director Ralph E. Christoffersen c/o Elcelyx Therapeutics, Inc. 11995 El Camino Real, Suite 305 San Diego CA CALIFORNIA 92130 Director Martin R. Brown c/o Elcelyx Therapeutics, Inc. 11995 El Camino Real, Suite 305 San Diego CA CALIFORNIA 92130 Executive Officer Jim Glasheen c/o Elcelyx Therapeutics, Inc. 11995 El Camino Real, Suite 305 San Diego CA CALIFORNIA 92130 Director Brook Byers c/o Elcelyx Therapeutics, Inc. 11995 El Camino Real, Suite 305 San Diego CA CALIFORNIA 92130 Director Biotechnology Decline to Disclose 06 true 0001486988-11-000001 2011-01-11 false true false 0 14125007 14125007 0 A Form D was timely filed for the first closing reflecting the amount of securities sold: $6,050,001.95. This Form D includes the amount of securities sold at the second closing on May 4, 2011 which was not previously determined: $8,075,005.60. false 7 0 0 0 false Elcelyx Therapeutics, Inc. /s/ Alain D. Baron, M.D. Alain D. Baron, M.D. President and Chief Executive Officer 2011-05-09